These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24397393)

  • 1. Validation of proteomic biomarkers previously found to be differentially expressed in women with polycystic ovary syndrome: a cross-sectional study.
    Haoula Z; Shaw B; Daykin C; Hodgman C; Layfield R; Atiomo W
    Gynecol Endocrinol; 2014 Mar; 30(3):213-6. PubMed ID: 24397393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum concentration of total inhibin in polycystic ovary syndrome.
    Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
    Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation.
    Insenser M; Martínez-García MA; Montes R; San-Millán JL; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3863-70. PubMed ID: 20484478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome.
    Carvalho LML; Ferreira CN; de Oliveira DKD; Rodrigues KF; Duarte RCF; Teixeira MFA; Xavier LB; Candido AL; Reis FM; Silva IFO; Campos FMF; Gomes KB
    J Assist Reprod Genet; 2017 Dec; 34(12):1691-1698. PubMed ID: 28900795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
    El-Mesallamy HO; Abd El-Razek RS; El-Refaie TA
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.
    Celik O; Sahin I; Celik N; Hascalik S; Keskin L; Ozcan H; Uckan A; Kosar F
    Hum Reprod; 2007 Nov; 22(11):2992-8. PubMed ID: 17855407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?
    Huang S; Qiao J; Li R; Wang L; Li M
    Fertil Steril; 2010 Jun; 94(1):205-10. PubMed ID: 19368908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
    Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
    Wijeyaratne CN; Nirantharakumar K; Balen AH; Barth JH; Sheriff R; Belchetz PE
    Clin Endocrinol (Oxf); 2004 May; 60(5):560-7. PubMed ID: 15104558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An appraisal of serum preptin levels in PCOS.
    Celik O; Celik N; Hascalik S; Sahin I; Aydin S; Ozerol E
    Fertil Steril; 2011 Jan; 95(1):314-6. PubMed ID: 20883990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome.
    Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance but not impaired β-cell function: a key feature in Chinese normal-weight PCOS women with normal glucose regulation.
    Li W; Ma L; Li Q
    Gynecol Endocrinol; 2012 Aug; 28(8):598-601. PubMed ID: 22309514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.
    Katsikis I; Karkanaki A; Misichronis G; Delkos D; Kandaraki EA; Panidis D
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):181-5. PubMed ID: 21353371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome.
    Tan BK; Chen J; Hu J; Amar O; Mattu HS; Adya R; Patel V; Ramanjaneya M; Lehnert H; Randeva HS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1891-900. PubMed ID: 24152681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
    Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
    Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.